Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1 year […]
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 1 year price […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its price target dropped by equities research analysts at Barclays from $230.00 to $200.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. Barclays‘s target price indicates a potential upside of 82.08% […]
Barclays Trims Jazz Pharmaceuticals (NASDAQ:JAZZ) Target Price to $200 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average twelve-month target […]